Portfolio
TechAviv's pre-seed founders fund backs and actively supports the world's elite Israeli founders.
.jpg)
Portfolio News
This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market
Five scientists walked into a lab late last year and decided to establish a startup combining their wide-ranging expertise, practical experience and breakthrough innovations. The goal of their startup, Somite.ai, is to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies. The market for the therapies for the diseases they aim to address is estimated at $250 billion.
Naftali Bennett and Michal Tsur unite at Remepy: Former PM joins Board
This is the third high-tech board Bennett has joined since he left politics, previously joining AI cyber company Lasoo and quantum computing startup Quantum Source. Tsur and Bennett founded Cyota in 1999 together with Ben Enosh and Lior Golan and sold it to RSA Security in 2005 for $145 million.